Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health expects its earnings and revenue to grow in the year ahead, as it focuses on making health care more affordable and easier for customers.

CVS says it expects earnings, revenue to grow in 2022 as it steps up health-care focus

WOONSOCKET, R.I., Dec. 9, 2021 /PRNewswire/ -- Today at its 2021 Investor Day, the CVS Health (NYSE: CVS) leadership team will present a strategy that capitalizes on the significant opportunity to make health care more convenient, personalized and affordable for consumers.

CVS Health Presents Strategy for Revolutionizing Consumer Health Experience While Driving Profitable Growth

The drugstore chain and health insurer is expected to lay out its plans to use health-care services as a growth engine beyond the Covid pandemic.

3 themes to watch as CVS has its first investor day since start of pandemic

CVS Health's (CVS) collaboration with Microsoft will accelerate digital transformation and empower employees to provide more customized and affordable care.

CVS Health (CVS) New Alliance to Boost Digital Transformation

The market is giving value-conscious investors an early Christmas gift.

Value Investors Will Love This Diversified Healthcare Stock

WOONSOCKET, R.I., Dec. 6, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) marks National Influenza Vaccination Week (December 5-11) by reminding everyone that it's not too late to get a flu shot.

CVS Health Reminds Americans to Get Their Flu Shot During National Influenza Vaccination Week

Microsoft

Microsoft (MSFT) will be teaming up with CVS Health to advance work on developing innovative solutions to boost customer health outcomes.

Microsoft (MSFT) to Support CVS Health's Digital Transformation

Costco

GameStop

Toll Brothers

AutoZone, Brown-Forman, Broadcom, and others will also report earnings. Economic data to be released this week include consumer credit for October and the consumer price index for November.

GameStop, Toll Brothers, Costco, CVS, and Other Stocks for Investors to Watch

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

CVS Health (CVS) Down 4.8% Since Last Earnings Report: Can It Rebound?

Energy Select Sector SPDR Fund

With strong earnings and a relatively inexpensive valuation, CVS Health could offer protection in a market showing cracks, says Joule Financial's Quint Tatro.

Buy these defensive plays for a potentially difficult December in the market, traders say

Connected healthcare keeps making new connections as firms from different parts of the business world join forces to drive greater digital transformation for millions of consumers. New evidence of the gathering trend comes from CVS Health and Microsoft, which on Thursday (Dec. 2) jointly announced an initiative combining Microsoft's Azure cloud computing platform with deep […]

CVS Health and Microsoft Link Up to Speed Healthcare's Digital Shift on Retail's Frontlines

Advanced Micro Devices

Amazon

Robinhood

Intel

Tesla

Verizon

Walgreens

Walmart

U.S. retirement savings today are heavily dependent on the stock market. Technology has transformed investor's understanding and access to the system and has unleashed the era of impatience.

This Isn't Your Father's Market: Long Live Income

CVS Health and Microsoft Announce New Strategic Alliance to Reimagine Personalized Care and Accelerate Digital Transformation

CVS Health and Microsoft Corp. have formed a strategic alliance to "reimagine personalized care" and "accelerate digital transformation" for the drugstore chain.

CVS Health, Microsoft Partner To Bring ‘Digital First' Care To Customers

WOONSOCKET, R.I., Nov. 30, 2021 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (NYSE: CVS) is now offering Spoken Rx™, its proprietary audio prescription label solution, in all its nearly 10,000 pharmacy locations nationwide, including more than 1,700 CVS Pharmacy locations within Target.

Spoken Rx™ "Talking" Prescription Labels Now Available in All CVS Pharmacy Locations

Moderna

Novavax

Pfizer

Check out these health care stocks that are heating up in the stock market right now.

4 Top Health Care Stocks To Watch In The Stock Market Today

Jurors in Cleveland federal court have determined that pharmacy chain operators CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance Inc (NASDAQ: WBA), and Walmart Inc (NYSE: WMT) helped fuel the opioid epidemic in two counties in Ohio, Reuters reports. The jurors concluded that the companies helped create a public nuisance through an abundant supply of pain killers and diversion of those drugs to the black market.

US Jury Finds Pharmacy Chains Did Not Monitor Opioid Usage, Thus Fueling Epidemic: Reuters

Agree Realty

Alexander & Baldwin

Federal Realty Investment Trust

Kimco Realty

NETSTREIT Corp

New York City REIT Inc

Realty Income Corp

Regency Centers

Spirit Realty Capital

CVS Health Corp. to close nearly 10% of its US locations over the next three years. In an agenda to improve profitability, the company plans to add new health services.

CVS To Close 900 Stores: Smart Move And REIT Landlords Benefit Too

CVS Health's (CVS) time-delay safes reduce theft and diversion of opioid medications and boost the security of stores, creating a safe environment for patients and staff.

CVS Health (CVS) Installs Time-Delay Safes in Texas Pharmacies

AstraZeneca

Bristol-Myers

Novartis

Patterson Companies

Needless to say, 2021 has been a banner year for equities, with the S&P 500 up a stunning 25%.

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

CVS Group (AIM:CVSG) PLC, the chain of veterinary surgeries, reported continued strong growth for the first four months of its financial years. Like-for-like sales were up 12.4% for the four months to 31 October, with total sales up 13.8% compared to the same period last year.

CVS Group sales and margins continue to climb

Stocks of drugmakers and pharmacies facing litigation over the opioid crisis were stable after two Ohio counties successfully sued CVS Health, Walgreens, and Walmart in U.S. District Court. The companies are expected to appeal.

Jury Finds Pharmacy Chains Contributed to Opioid Crisis

A federal jury said CVS, Walgreens and Walmart helped fuel the opioid abuse crisis in two Ohio counties, the first verdict in a lawsuit of its kind.

CVS, Walgreens, Walmart Found Liable For Distributing Painkillers

A federal jury on Tuesday found that pharmacy chain operators CVS, Walgreens Boots Alliance and Walmart helped fuel an opioid epidemic in two Ohio counties, in the first trial the companies have faced over the US drug crisis. Jurors in Cleveland federal court concluded that actions by the pharmacy chains helped create a public nuisance that resulted.

CVS, other pharmacy chains lose Ohio suit in first opioid epidemic trial

The opioid crisis has killed a half-million Americans over the past two decades. The jury's verdict could impact pharmacy accountability.

News for CVS Health Stock (CVS)